JOHNSON & JOHNSON Other Non-current Liabilities 2008-2026 | JNJ
Beta
What is JOHNSON & JOHNSON's current other non-current liabilities?
JOHNSON & JOHNSON (JNJ) annual other non-current liabilities for 2025 was $9.87B, a 43.77% decline from 2024. JOHNSON & JOHNSON other non-current liabilities for the quarter ending March 29, 2026 was $10.21B.
What was JOHNSON & JOHNSON's other non-current liabilities in 2024?
JOHNSON & JOHNSON annual other non-current liabilities for 2024 was $17.55B, a 30.98% increase from 2023.
What was JOHNSON & JOHNSON's other non-current liabilities in 2023?
JOHNSON & JOHNSON annual other non-current liabilities for 2023 was $13.40B, a 25.38% increase from 2022.
What is JOHNSON & JOHNSON's 4-year other non-current liabilities CAGR?
JOHNSON & JOHNSON other non-current liabilities grew at a compound annual growth rate (CAGR) of 4.66% from FY2021 to FY2025, going from $11.94B to $9.87B over 4 years.
Other Non-current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-3.4%
FY2019
$11.73B
→
FY2025
$9.87B
081011121314161718192122232425
5 years selected
Other Non-current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $9.87B | -43.8% | 10-K |
| FY2024 | $17.55B | +31.0% | 10-K |
| FY2023 | $13.40B | +25.4% | 10-K |
| FY2022 | $10.69B | -10.5% | 10-K |
| FY2021 | $11.94B | +1.8% | 10-K |
| FY2019 | $11.73B | +36.6% | 10-K |
| FY2018 | $8.59B | -4.7% | 10-K |
| FY2017 | $9.02B | -12.0% | 10-K |
| FY2016 | $10.24B | +27.5% | 10-K |
| FY2014 | $8.03B | +2.3% | 10-K |
| FY2013 | $7.85B | -8.2% | 10-K |
| FY2012 | $8.55B | +30.2% | 10-K |
| FY2011 | $6.57B | +10.4% | 10-K |
| FY2010 | $5.95B | +41.4% | 10-K |
| FY2008 | $4.21B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →